Regeneron Pharmaceuticals (REGN)
EBITDA
$1.66B
Quarterly · Period ending: · USD
REGN EBITDA
Latest reported$1.66Bperiod ending
Latest reported$1.66Bperiod ending
REGN Quarterly EBITDA ($1.20M → $1.66B)
Quarterly EBITDA
High-resolution chart · PNG
REGN ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 1,662,500,000 | |
| 967,300,000 | |
| 1,200,900,000 | |
| 1,919,300,000 | |
| 1,657,400,000 | |
| 1,040,600,000 | |
| 1,095,000,000 | |
| 1,628,500,000 | |
| 1,763,600,000 | |
| 830,900,000 | |
| 1,278,900,000 | |
| 1,234,000,000 | |
| 1,204,900,000 | |
| 975,500,000 | |
| 1,442,200,000 | |
| 1,617,700,000 | |
| 1,050,700,000 | |
| 1,149,000,000 | |
| 2,592,000,000 | |
| 1,904,000,000 | |
| 3,838,300,000 | |
| 1,335,000,000 | |
| 1,301,100,000 | |
| 1,083,900,000 | |
| 987,400,000 | |
| 730,800,000 | |
| 950,800,000 | |
| 829,200,000 | |
| 284,800,000 | |
| 604,800,000 | |
| 726,308,000 | |
| 678,796,000 | |
| 696,634,000 | |
| 628,195,000 | |
| 595,309,000 | |
| 609,506,000 | |
| 566,377,000 | |
| 477,905,000 | |
| 370,427,000 | |
| 393,942,000 | |
| 316,657,000 | |
| 352,285,000 | |
| 253,992,000 | |
| 413,096,000 | |
| 360,157,000 | |
| 299,580,000 | |
| 229,938,000 | |
| 196,724,000 | |
| 235,422,000 | |
| 197,469,000 | |
| 223,365,000 | |
| 247,605,000 | |
| 168,759,000 | |
| 162,913,000 | |
| 155,832,000 | |
| 212,210,000 | |
| 97,396,000 | |
| 31,227,000 | |
| -36,677,000 | |
| -49,466,000 | |
| -51,419,000 | |
| -32,966,000 | |
| -4,569,000 | |
| -26,747,000 | |
| -19,792,000 | |
| -24,255,000 | |
| -33,920,000 | |
| 2,299,000 | |
| -13,268,000 | |
| -18,257,000 | |
| -25,650,000 | |
| -17,157,000 | |
| -16,678,000 | |
| -12,965,000 | |
| -8,635,000 | |
| -35,808,000 | |
| -27,730,000 | |
| -30,794,000 | |
| -30,090,000 | |
| -24,549,000 | |
| -20,559,000 | |
| -17,865,000 | |
| 223,195,000 | |
| -30,452,000 | |
| -28,336,000 | |
| -24,482,000 | |
| 7,890,000 | |
| -7,020,000 | |
| -9,951,000 | |
| 23,794,000 | |
| -12,825,000 | |
| -22,047,000 | |
| -26,932,000 | |
| -26,091,000 | |
| -32,585,000 | |
| -30,008,000 | |
| -27,722,000 | |
| -23,185,000 | |
| -27,783,000 | |
| -21,775,000 |